Terug
Dagbereik
€ 9,18
€ 9,70
52-Weeksbereik
€ 8,70
€ 22,96
Volume
599.290
50D / 200D Gem.
€ 11,06
/
€ 12,79
Vorige Slotkoers
€ 9,54
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,4 | 0,2 |
| P/B | 0,7 | 3,0 |
| ROE % | -39,9 | 3,6 |
| Net Margin % | -31,6 | 3,8 |
| Rev Growth 5Y % | 1,5 | 9,9 |
| D/E | 2,0 | 0,2 |
Koersdoel Analisten
Hold
€ 15,00
+57.1%
Forward K/W
4,07
Forward WPA
€ 2,35
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,67B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 2,74
€ 2,71 – € 2,76
|
1,78B | 1 |
| FY2027 |
€ 2,55
€ 2,49 – € 2,62
|
1,73B | 5 |
| FY2026 |
€ 2,35
€ 2,30 – € 2,37
|
1,67B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | € 0,80 | € 0,83 | +3,8% |
| 2025-10-30 | € 0,43 | € 0,54 | +25,6% |
| 2025-07-31 | € 0,43 | € 0,45 | +4,7% |
| 2025-05-05 | € 0,43 | € 0,41 | -4,7% |
| 2025-02-25 | € 0,86 | € 0,97 | +12,8% |
| 2024-11-04 | € 0,39 | € 0,41 | +5,1% |
| 2024-07-29 | € 0,62 | € 0,63 | +1,6% |
| 2024-05-06 | € 0,55 | € 0,55 | 0,0% |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 |
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
|
grant | 70.305 | — | — |
| Mar 11, 2026 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
other | 8.089 | € 9,61 | € 77.735,29 |
| Mar 11, 2026 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
grant | 111.179 | — | — |
| Mar 11, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
other | 8.487 | € 9,61 | € 81.560,07 |
| Mar 11, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
grant | 43.350 | — | — |
| Mar 11, 2026 |
McBreen Michael J.
EVP & President, CSS
|
other | 7.247 | € 9,61 | € 69.643,67 |
| Mar 11, 2026 |
McBreen Michael J.
EVP & President, CSS
|
grant | 92.108 | — | — |
| Mar 10, 2026 |
DAVIS ROBERT T. JR.
EVP & President, TT
|
other | 687 | € 9,55 | € 6.560,85 |
| Mar 10, 2026 |
McBreen Michael J.
EVP & President, CSS
|
other | 2.354 | € 9,55 | € 22.480,70 |
| Feb 2, 2026 |
Hutchinson Michael Damon
EVP, Chief Legal Officer & Sec
|
grant | 89.606 | — | — |
| Nov 5, 2025 |
GRAVES JEFFREY A
Director
|
buy | 9.000 | € 11,35 | € 102.150,00 |
| Oct 12, 2025 |
Singh Harvinder
EVP & PRESIDENT, INTERNATIONAL
|
other | 27.211 | — | — |
| Jul 3, 2025 |
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
|
other | 3.345 | € 13,49 | € 45.124,05 |
| Jul 3, 2025 |
Knight Lea Daniels
EVP & Chief Financial Officer
|
other | 2.561 | € 13,49 | € 34.547,89 |
| Jul 1, 2025 |
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
|
other | 937 | € 13,25 | € 12.415,25 |
| May 9, 2025 |
BRADLEY KEITH
Director
|
other | 392 | € 12,25 | € 4.802,00 |
| May 9, 2025 |
BRADLEY KEITH
Director
|
grant | 19.592 | — | — |
| May 9, 2025 |
HILL BARBARA B
Director
|
grant | 26.531 | — | — |
| May 9, 2025 |
Clay Shaundra
Director
|
grant | 19.592 | — | — |
| May 9, 2025 |
Lo Renee Wonlai
Director
|
grant | 19.592 | — | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 1,47% annually over 5 years — modest growth
Negative free cash flow of -31,05M
Capital efficient — spends only 4,98% of revenue on capex
ROIC of 1,67% — low return on invested capital
Interest coverage of 0,79× — tight debt servicing
Groei
Revenue Growth (5Y)
1,47%
Revenue (1Y)1,53%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-39,90%
ROIC1,67%
Net Margin-31,58%
Op. Margin4,18%
Veiligheid
Debt / Equity
1,95
Current Ratio2,54
Interest Coverage0,79
Waardering
P/E Ratio
-1,44
Forward P/E4,07
P/B Ratio0,71
EV/EBITDA37,21
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,53% | Revenue Growth (3Y) | 2,99% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 1,47% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,64B | Net Income (TTM) | -516,47M |
| ROE | -39,90% | ROA | -14,34% |
| Gross Margin | 51,69% | Operating Margin | 4,18% |
| Net Margin | -31,58% | Free Cash Flow (TTM) | -31,05M |
| ROIC | 1,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,95 | Current Ratio | 2,54 |
| Interest Coverage | 0,79 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,44 | Forward P/E | 4,07 |
| P/B Ratio | 0,71 | P/S Ratio | 0,46 |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | 37,21 | Fwd EV/EBITDA | 13,29 |
| Forward P/S | 0,44 | Fwd Earnings Yield | 24,57% |
| FCF Yield | -4,17% | ||
| Market Cap | 744,30M | Enterprise Value | 2,54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,64B | 1,61B | 1,54B | 1,56B | 1,54B |
| Net Income | -516,47M | -6,94M | 67,74M | 180,55M | 169,08M |
| EPS (Diluted) | -6,73 | -0,09 | 0,84 | 2,16 | 1,98 |
| Gross Profit | 845,23M | 882,06M | 884,74M | 970,31M | 944,64M |
| Operating Income | 68,32M | 28,41M | 111,53M | 238,92M | 197,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,60B | 4,04B | 3,78B | 3,89B | 3,78B |
| Total Liabilities | 2,56B | 2,49B | 2,19B | 2,09B | 2,10B |
| Shareholders' Equity | 1,04B | 1,55B | 1,59B | 1,80B | 1,68B |
| Total Debt | 2,03B | 1,98B | 1,68B | 1,63B | 1,67B |
| Cash & Equivalents | 235,05M | 246,38M | 276,40M | 456,66M | 513,45M |
| Current Assets | 1,16B | 1,08B | 1,06B | 1,16B | 1,15B |
| Current Liabilities | 455,98M | 922,13M | 306,98M | 320,91M | 340,02M |